You are here: Industry Insights > SARS-CoV-2

News List

Genome analyses track SARS-CoV-2's early introduction to the US and Europe worldpharmanews
September 14, 2020
SARS-CoV-2 arrived in Washington State somewhere between late January and early February 2020, sparking rapid community transmission of the virus that went undetected for several weeks before this community spread became evident ...
iBio Advances COVID-19 Vaccine Candidate contractpharma
September 14, 2020
IBIO-201 induced the production of anti-spike neutralizing antibodies in tests.
COVAXIN demonstrates protective efficacy in animal studies: Bharat Biotech expresspharma
September 14, 2020
A two-dose vaccination regimen, administered in 20 rhesus macques, showed increasing SARS-CoV-2 specific IgG and neutralizing antibodies, reducing replication of the virus in the nasal cavity, throat, and lung tissues.
Twist Bioscience announces potent SARS-CoV-2 neutralising data from Covid-19 therapeutic antibody programme pharmaceutical-business-review
September 08, 2020
Twist Bioscience announced data demonstrating the potent neutralizing effects of multiple potential therapeutic antibodies, both Immunoglobulin G (IgG) antibodies and substantially smaller single domain VHH “nanobodies,” against SARS-CoV-2, the virus ...
Janssen's lead coronavirus vaccine shows preclinical promise pharmatimes
September 07, 2020
Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters when challenged with SARS-CoV-2, the virus that causes COVID-19 in people.
ADMA Biologics Launches COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay americanpharmaceuticalreview
September 04, 2020
ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
J&J’s Covid-19 vaccine prevents severe disease in preclinical tests pharmaceutical-technology
September 04, 2020
Johnson & Johnson (J&J) has reported that a Covid-19 vaccine candidate, developed by the company’s subsidiary Janssen, prevented severe disease in preclinical studies.
Adma Biologics Launches COVID-19 Assay contractpharma
September 04, 2020
Adma Biologics Inc., an end-to-end commercial biopharmaceutical company, has launched COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
Roche to launch SARS-CoV-2 rapid antigen test pharmatimes
September 03, 2020
Roche is gearing up to launch an antigen test able to “reliably and quickly” triage people suspected of SARS-CoV-2, with results available in just 15 minutes.
MediciNova Announces Development Progress on Intranasal Formulation of COVID-19 Vaccine americanpharmaceuticalreview
September 02, 2020
MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a viral vector platform technology developed by Mie University and BioComo.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page